Traditional vaccines work by stimulating the immune system, but their effectiveness is often limited by how well they can ...

AC Immune has reported additional interim safety and positive immunogenicity outcomes from its placebo-controlled Phase II ...

New research led by Yale School of Medicine (YSM) advances the goals of creating a diagnostic test and vaccines for ...

Immune response data from FLAMINGO-01 shows positive results in patients with HER2+ breast cancer, suggesting potential for ...

AC Immune (ACIU) announced additional interim safety and positive immunogenicity data from the Phase 2 VacSYn clinical trial evaluating ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase ...

Imagine a super-charged immune cell that can launch a focused attack on stubborn solid tumors—a smart fighter that destroys ...

Immune cells are generated to keep our bodies healthy. To combat disease, our bodies initiate two separate waves of immunity.

Several studies have been conducted, but questions remain about where such therapies will fit into multiple myeloma treatment ...

EVM14 received U.S. FDA clearance for its IND application, becoming Everest's first internally discovered program, and the first mRNA therapeutic cancer vaccine to be cleared for global clinical ...